Healthcare Triangle, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
HCTI$4.21-0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance sheets
Condensed Consolidated Balance Sheets
| June 30, · December 31, | |||
|---|---|---|---|
| Note | 2026 | 2025 | |
| (Unaudited) · (Audited) | |||
| Assets | |||
| Current assets | |||
| Cash and cash equivalents | $1,906 | $7,625 | |
| Accounts receivable, net | 3 | 6,186 | 2,070 |
| Other current assets | 5 | 1,554 | 3,456 |
| Total current assets | 9,646 | 13,151 | |
| Advances, net | 4 | 3,260 | 3,826 |
| Furniture and equipment, net | 7 | 1,192 | 5 |
| Other intangible assets, net | 6 | 54,825 | 2,808 |
| Goodwill | 6 | 2,946 | 2,946 |
| Operating lease right-of-use assets | 8 | 1,193 | - |
| Other non-current assets | 201 | - | |
| Deferred tax asset, net | 377 | - | |
| Total assets | $73,640 | $22,736 | |
| Liabilities and stockholders’ equity | |||
| Current liabilities | |||
| Accounts payable | $1,199 | $744 | |
| Short-term debt | 9 | 9,165 | 10,737 |
| Operating lease liabilities – current | 8 | 426 | - |
| Other current liabilities | 10 | 5,200 | 1,311 |
| Total current liabilities | 15,990 | 12,792 | |
| Non-current liabilities | |||
| Long-term debt | 9 | 2,662 | - |
| Operating lease liabilities - non-current | 8 | 747 | - |
| Contingent consideration | 11 | 5,000 | - |
| Other non-current liabilities | 142 | - | |
| Total current and non-current liabilities | 24,541 | 12,792 | |
| Stockholders’ equity | 12 | ||
| Preferred stock, par value $0.00001; 10,000,000 authorized | |||
| Series A super voting preferred stock - 20,000 shares (1,000 votes per share) issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | - | - | |
| Series B convertible preferred stock, 1,600,000 issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | 7,435 | 7,435 | |
| Series C convertible preferred stock (to be issued) – see note 12(B) | 18,000 | - | |
| Common stock, par value $0.00001; 2,000,000,000 authorized, 2,027,719 and 142,426 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | 11 | 11 | |
| Common stock (to be issued) – see note 12(A) | 12,000 | - | |
| Non-controlling interest | (89) | (37) | |
| Additional paid-in capital | 65,231 | 45,534 | |
| Accumulated deficit | (53,489) | (42,999) | |
| Total stockholders’ equity | 49,099 | 9,944 | |
| Total liabilities and stockholders’ equity | $73,640 | $22,736 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.